Study validates disc diffusion method to sort vaccine and field Salmonella

A newly published study in Veterinary Sciences tackles a familiar surveillance headache in poultry medicine: how to tell a live vaccine strain from a true field isolate when Salmonella turns up in a flock. The paper, titled Reliable Differentiation of a Bivalent Live Salmonella Vaccine and Field Strains: Multi-Supplier Validation of a Disc Diffusion Method, focuses on Salmonella Enteritidis and Salmonella Typhimurium, the serovars most often implicated in poultry-linked human disease. Its premise is straightforward but operationally important: if vaccination is part of control, diagnostics have to keep pace. (efsa.europa.eu)

That need isn’t theoretical. WOAH guidance for poultry Salmonella control explicitly says that if live vaccines are used, field and vaccine strains should be easily differentiated in the laboratory, and it notes that serology may not be able to separate vaccination from infection. In practice, that distinction influences whether a positive result is treated as expected post-vaccination detection, a biosecurity breach, or a potentially reportable field event. (woah.org)

The background is also getting more complicated, not less. Live attenuated Salmonella vaccines are well established in poultry production because they help reduce flock prevalence and downstream food-chain risk. But recent research has shown why differentiation remains a live issue: vaccine-origin S. Typhimurium can persist through the poultry production continuum, and researchers have developed new PCR typing schemes specifically to separate vaccine-derived strains from wild-type isolates. In Spain, a 2025 validation study of a qPCR DIVA assay for the Primun Salmonella T vaccine argued that accurate differentiation is essential to preserve surveillance integrity and avoid unnecessary slaughter or other costly interventions. (pmc.ncbi.nlm.nih.gov)

Against that backdrop, the new Veterinary Sciences paper appears to position disc diffusion as a more practical, multi-supplier-validated option for distinguishing a bivalent live vaccine from field strains. That’s notable because older antibiogram-based approaches can be useful, but they also have limits. The Spanish qPCR validation study pointed out that resistance-profile methods depend on the continued stability of antimicrobial susceptibility patterns in circulating wild strains, and that overlap can eventually undermine confidence in phenotypic differentiation alone. In other words, the value of a disc diffusion workflow depends on how robustly it performs across suppliers, labs, and strain backgrounds. (mdpi.com)

Industry and research activity suggests the field is moving on two tracks at once. One track is toward simpler lab workflows that can be used widely; the other is toward faster, more specific molecular DIVA tools. Recent publications describe PCR assays that distinguish vaccine-origin S. Typhimurium from wild-type isolates, while the Spanish duplex qPCR kit reported results in under 40 minutes from isolated colonies, compared with 24 hours or longer for antibiogram-based identification. That doesn’t make phenotypic methods obsolete, but it does raise the bar for where they fit best, especially in routine surveillance networks with mixed laboratory capacity. (pmc.ncbi.nlm.nih.gov)

Why it matters: For veterinarians, diagnostic labs, and poultry integrators, this is really a story about decision quality. A reliable way to sort vaccine strains from field strains can reduce unnecessary movement restrictions, culling decisions, traceback efforts, and client anxiety, while preserving confidence in vaccination programs. It also supports the larger One Health objective behind poultry Salmonella control: S. Enteritidis remains a leading cause of foodborne outbreaks in Europe, and poultry remains a key reservoir. The more confidently labs can interpret positives in vaccinated flocks, the better the industry can balance disease prevention, surveillance, and regulatory compliance. (efsa.europa.eu)

What to watch: The next step is whether independent labs and control programs replicate the study’s performance in day-to-day use, and whether regulators and surveillance networks favor a validated disc diffusion method as a practical screening tool, a bridge to molecular confirmation, or both. Longer term, expect continued pressure for methods that are not just accurate, but fast, standardized, and workable across different laboratory settings. (mdpi.com)